What is the major result of alpha-1 antagonist administration?

The NBME Form 31 Test is your guide to mastering medical examinations. Engage with questions, explore detailed explanations, and enhance your medical knowledge. Get exam-ready now!

Administering an alpha-1 antagonist primarily leads to orthostatic hypotension due to its mechanism of action. Alpha-1 adrenergic receptors are responsible for vasoconstriction; when these receptors are blocked, there is a reduction in peripheral vascular resistance, which can lead to a drop in blood pressure, especially upon standing.

When a patient stands, gravity causes blood to pool in the lower extremities, and normally, alpha-1 receptors help to maintain blood pressure by constricting blood vessels. With these receptors blocked, there is less vasoconstriction, resulting in an inability to counteract this gravitational effect, leading to orthostatic hypotension. This condition can manifest as dizziness or light-headedness when the patient stands up due to a drop in cerebral perfusion.

This understanding of alpha-1 antagonists is critical, particularly in clinical settings where managing blood pressure and understanding the side effects of antihypertensive medications are essential for patient safety and comfort.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy